名稱(chēng) | Human ADORA3 Ga15/CHO |
型號(hào) | CBP71338 |
報(bào)價(jià) | ![]() |
特點(diǎn) | Human ADORA3 Ga15/CHO 凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- GLP1R藥靶篩選模型應(yīng)用展示
- 4-1BB(CD137)靶點(diǎn)藥物篩選模型
- 【新品發(fā)布】MRD標(biāo)準(zhǔn)品_40+位點(diǎn)panel標(biāo)準(zhǔn)品
- 是激活還是沉默?基因表達(dá)的新路徑
- 分子診斷標(biāo)準(zhǔn)品,匠心出品,免費(fèi)申領(lǐng)
- 【連載-企業(yè)參考品】肺癌PCR和NGS參考品的選擇
- 腫瘤細(xì)胞的信息系統(tǒng)的改變特征大揭秘
- RET基因如何檢測(cè)?
- 【連載-企業(yè)參考品】胃腸道間質(zhì)瘤的PCR和NGS參考品的選擇
- 剛收到的細(xì)胞株如何進(jìn)行合理的處理?
聯(lián)系我們
電話(huà):4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > GPCR細(xì)胞株 > CBP71338Human ADORA3 Ga15/CHO

- 詳細(xì)內(nèi)容
CBP71338 | |
I. Background | |
Extracellular adenosine mediates a multitude of biological effects, including wakefulness, antiarrythmia, bronchoconstriction and response to ischemia and oxidative stress. A family of four G-protein coupled adrenoceptors, A1, A2A, A2B and A3, is responsible for these effects. A3, which couples to Gi/o, is expressed in a wide range of human tissues, but most predominantly in the lung and liver. Recent animal model studies have shown that A3 receptors play important roles in brain ischemia, immunosuppresion, and bronchospasm. A3 receptor agonists and/or agonists may have important clinical value in the treatment of asthma and inflammation. Mice lacking A3 receptors display reduced mast cell degranulation and bronchoconstriction in response to adenosine. | |
II. Introduction | |
Host Cell: | CHO |
Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | F12K+10% FBS+2 μg/ml puromycin+ 100 μg/ml Hygromycin B |
Mycoplasma Status: | Negative |
Storage: | Liquid nitrogen immediately upon delivery |
Application(s): | Functional assays for ADORA3 receptor |
Transducer: | Gi |
Ⅲ. Description of Host Cell Line | |
Organism: | Hamster |
Tissue: | Ovary |
Morphology: | Epithelial |
Growth Properties: | Adherent |
Ⅳ. Representative Data |